A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Public ClinicalTrials.gov record NCT07614776. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-masked, Comparative Clinical Study Evaluating the Efficacy, Safety, and Immunogenicity of ABP 938 8 mg Versus EYLEA® HD (Aflibercept) Delivered Via Intravitreal Injection in Participants With Neovascular Age-related Macular Degeneration
Study identification
- NCT ID
- NCT07614776
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 304 participants
Conditions and interventions
Conditions
Interventions
- ABP 938 8 mg Drug
- Aflibercept (US) 8 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 26, 2026
- Primary completion
- Jul 30, 2027
- Completion
- Jan 11, 2028
- Last update posted
- Jun 21, 2026
2026 – 2028
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| South Coast Retina Center - RCA | Long Beach | California | 90607 | Recruiting |
| California Eye Specialists Medical Group, Inc | Pasadena | California | 91107 | Recruiting |
| Retinal Consultants Medical Group, Inc - Sacramento - Parkcenter Drive (RCA) | Sacramento | California | 95825 | Recruiting |
| Medeye Associates - Research | Miami | Florida | 33143 | Recruiting |
| Advanced Research, LLC | Pensacola | Florida | 32503 | Recruiting |
| Retina Associates | Elmhurst | Illinois | 60126 | Recruiting |
| Retina Specialists | Towson | Maryland | 21204 | Recruiting |
| Retina Consultants of Minnesota | Edina | Minnesota | 55435 | Recruiting |
| Mississippi Retina Assoc | Madison | Mississippi | 39110 | Recruiting |
| Vision Research Center Eye Associates of New Mexico | Albuquerque | New Mexico | 87109 | Recruiting |
| Charleston Neuroscience Institute | Charleston | South Carolina | 29414-5896 | Recruiting |
| Palmetto Retina Center - Main (RCA) | Columbia | South Carolina | 29169 | Recruiting |
| Retina Consultants of South Carolina, Charleston Neuroscience Institute- Ladson (RCA) | Ladson | South Carolina | 29456 | Recruiting |
| Palmetto Retina Center, Florence (RCA) | West Columbia | South Carolina | 29169 | Recruiting |
| Texas Retina Associates (TRA) - Arlington | Arlington | Texas | 76012 | Recruiting |
| Texas Retina Associates (TRA) - Dallas Main | Dallas | Texas | 75231 | Recruiting |
| Texas Retina Associates - Fort Worth | Fort Worth | Texas | 76104 | Recruiting |
| Retina Consultants of Texas - Katy Retina Center | Houston | Texas | 77401 | Recruiting |
| Retina Consultants of Texas - Schertz | Schertz | Texas | 78154 | Recruiting |
| Vitreoretinal Associates of Washington | Bellevue | Washington | 98004-3779 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07614776, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2026 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07614776 live on ClinicalTrials.gov.